Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FT2HV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,013
Award facts
- Contract value 100% obligated
- $12,013.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (60-count units), a prescription medication for chronic obstructive pulmonary disease treatment. This firm fixed-price delivery order, valued at approximately $12,013, carries an ultimate completion date of December 11, 2025, and represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The vendor maintains a significant Indefinite Delivery/Indefinite Quantity (IDIQ) contract with DLA Troop Support Medical (SPE2DX) valued at $999,999,999 through December 2026, which serves as the umbrella vehicle enabling delivery orders such as this one.
This delivery order demonstrates AmerisourceBergen's role within the Defense Health Agency's pharmaceutical supply chain, providing brand-name medications through a flexible contracting mechanism that allows rapid fulfillment of military healthcare needs. The company's extensive federal contract portfolio reflects its capacity to deliver specialty pharmaceuticals across multiple therapeutic domains to support DoD medical operations globally. As a child contract under the larger SPE2DX IDIQ, this award exemplifies the government's strategy of utilizing prime vendor contracts to ensure consistent access to critical pharmaceutical products for military medical facilities and personnel.
Quick answers
Who was awarded contract SPE2DR26FT2HV?
SPE2DR26FT2HV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FT2HV worth?
The government has obligated $12,013 on SPE2DR26FT2HV.
Is contract SPE2DR26FT2HV an order under another contract?
Yes. SPE2DR26FT2HV is a delivery order under SPE2DR25D3109, an indefinite delivery contract.
Was contract SPE2DR26FT2HV competed?
The extent of competition for SPE2DR26FT2HV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award